Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (160) Apply Press releases filter
- Basic page (29) Apply Basic page filter
- Pipeline (19) Apply Pipeline filter
- Corporate presentations (16) Apply Corporate presentations filter
- Shareholder meeting (16) Apply Shareholder meeting filter
- Team member (15) Apply Team member filter
- Videos (14) Apply Videos filter
- Financial reports (9) Apply Financial reports filter
- Analyst (6) Apply Analyst filter
- Webcasts and audio (5) Apply Webcasts and audio filter
- Event (3) Apply Event filter
- Investor contact (3) Apply Investor contact filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
TR1 Form
RNS Number : 7931M
Oxford Biomedica PLC
29 August 2013
Interim Results 2013
RNS Number : 6906M
Oxford Biomedica PLC
29 August 2013
US$1 million Milestone Payment from Pfizer
RNS Number : 5892M
Oxford Biomedica PLC
28 August 2013
Announced as Funding Competition Winner
RNS Number : 6971L
Oxford Biomedica PLC
14 August 2013
Publication of TroVax Phase II Analyses
RNS Number : 3083K
Oxford Biomedica PLC
29 July 2013
Notice of Interim Results
RNS Number : 8846J
Oxford Biomedica PLC
23 July 2013
Director/PDMR Shareholding
RNS Number : 4246J
Oxford Biomedica PLC
16 July 2013
Update on Glaucoma-GT
RNS Number : 2020I
Oxford Biomedica PLC
01 July 2013
Total Voting Rights
RNS Number : 0653I
Oxford Biomedica PLC
28 June 2013
Director/PDMR Shareholding
RNS Number : 4929H
Oxford Biomedica PLC
20 June 2013